Full text 
Texts adopted
PDF 106kWORD 31k
Thursday, 13 September 2012 - Strasbourg Final edition
Tackling multiple sclerosis in Europe

Declaration of the European Parliament of 13 September 2012 on tackling multiple sclerosis in Europe

The European Parliament ,

–  having regard to Rule 123 of its Rules of Procedure,

A.  whereas approximately 600 000 Europeans suffer from multiple sclerosis (MS), which is the most common neurodegenerative disorder and is a major cause of non-traumatic disability in young adults;

B.  whereas most people with MS are diagnosed in the prime of their working lives, and almost half leave the workforce within three years of diagnosis;

C.  whereas in Europe tremendous discrepancies in access to disease-modifying treatments and quality of care exist, and have worsened in recent months;

1.  Calls on the Commission and Council to:

   encourage, within the framework of Horizon 2020, closer scientific collaboration and comparative research on MS;
   promote, in their Reflection Process on Chronic Disease, equal access to treatment and flexible employment policies for people with chronic neurological disorders such as MS;

2.  Calls on the Member States to:

   enhance equal access to quality care, for example. by using certified educational training tools (such as ’MS Nurse Professional’) to develop, standardise and benchmark specialist nursing staff training;
   support the European Register for MS by encouraging patient data collection at national level;

3.  Instructs its President to forward this declaration, together with the names of the signatories(1) , to the Council, the Commission and the Parliaments of the Member States.

(1) The list of signatories is published in Annex 1 to the Minutes of 13 September 2012 (P7_PV(2012)09-13(ANN1)).

Last updated: 19 July 2018Legal notice